| viral process | GO:0016032 | 41 | 0.865 | |
| interspecies interaction between organisms | GO:0044419 | 83 | 0.806 | |
| regulation of symbiosis encompassing mutualism through parasitism | GO:0043903 | 52 | 0.731 | |
| negative regulation of multi organism process | GO:0043901 | 68 | 0.695 | |
| regulation of innate immune response | GO:0045088 | 91 | 0.632 | |
| viral life cycle | GO:0019058 | 36 | 0.593 | |
| innate immune response | GO:0045087 | 157 | 0.581 | |
| negative regulation of viral genome replication | GO:0045071 | 10 | 0.510 | |
| symbiosis encompassing mutualism through parasitism | GO:0044403 | 83 | 0.497 | |
| viral genome replication | GO:0019079 | 17 | 0.496 | |
| defense response to virus | GO:0051607 | 68 | 0.474 | |
| immune response activating signal transduction | GO:0002757 | 116 | 0.438 | |
| negative regulation of viral process | GO:0048525 | 23 | 0.317 | |
| regulation of defense response to virus by host | GO:0050691 | 8 | 0.309 | |
| activation of innate immune response | GO:0002218 | 56 | 0.306 | |
| pattern recognition receptor signaling pathway | GO:0002221 | 47 | 0.260 | |
| positive regulation of innate immune response | GO:0045089 | 80 | 0.251 | |
| positive regulation of interferon alpha production | GO:0032727 | 4 | 0.249 | |
| regulation of multi organism process | GO:0043900 | 111 | 0.248 | |
| defense response to bacterium | GO:0042742 | 119 | 0.240 | |
| activation of immune response | GO:0002253 | 138 | 0.218 | |
| innate immune response activating signal transduction | GO:0002758 | 50 | 0.217 | |
| cytokine production | GO:0001816 | 319 | 0.201 | |
| immune effector process | GO:0002252 | 321 | 0.187 | |
| defense response to other organism | GO:0098542 | 197 | 0.180 | |
| toll like receptor signaling pathway | GO:0002224 | 38 | 0.179 | |
| positive regulation of defense response | GO:0031349 | 124 | 0.179 | |
| regulation of cytokine production | GO:0001817 | 266 | 0.176 | |
| leukocyte mediated immunity | GO:0002443 | 174 | 0.157 | |
| adaptive immune response | GO:0002250 | 155 | 0.151 | |
| regulation of interferon beta production | GO:0032648 | 13 | 0.144 | |
| regulation of viral genome replication | GO:0045069 | 13 | 0.139 | |
| positive regulation of type i interferon production | GO:0032481 | 14 | 0.137 | |
| interferon beta biosynthetic process | GO:0045350 | 4 | 0.136 | |
| cellular response to type i interferon | GO:0071357 | 10 | 0.135 | |
| regulation of defense response | GO:0031347 | 233 | 0.130 | |
| covalent chromatin modification | GO:0016569 | 163 | 0.126 | |
| positive regulation of type i interferon mediated signaling pathway | GO:0060340 | 4 | 0.124 | |
| interferon beta production | GO:0032608 | 16 | 0.116 | |
| positive regulation of cytokine production | GO:0001819 | 174 | 0.115 | |
| regulation of toll like receptor signaling pathway | GO:0034121 | 20 | 0.114 | |
| response to type i interferon | GO:0034340 | 12 | 0.111 | |
| cellular response to lipid | GO:0071396 | 145 | 0.105 | |
| extrinsic apoptotic signaling pathway | GO:0097191 | 126 | 0.098 | |
| type i interferon production | GO:0032606 | 29 | 0.097 | |
| negative regulation of cell proliferation | GO:0008285 | 296 | 0.095 | |
| regulation of sequence specific dna binding transcription factor activity | GO:0051090 | 106 | 0.093 | |
| cellular response to lipopolysaccharide | GO:0071222 | 77 | 0.091 | |
| lymphocyte activation involved in immune response | GO:0002285 | 93 | 0.089 | |
| t helper 17 cell lineage commitment | GO:0072540 | 4 | 0.089 | |
| protein modification by small protein conjugation | GO:0032446 | 187 | 0.088 | |
| response to lipopolysaccharide | GO:0032496 | 128 | 0.088 | |
| epidermis development | GO:0008544 | 187 | 0.087 | |
| lipopolysaccharide mediated signaling pathway | GO:0031663 | 25 | 0.087 | |
| regulation of myd88 independent toll like receptor signaling pathway | GO:0034127 | 1 | 0.087 | |
| immune response regulating signaling pathway | GO:0002764 | 125 | 0.086 | |
| cytokine biosynthetic process | GO:0042089 | 68 | 0.086 | |
| cellular response to molecule of bacterial origin | GO:0071219 | 83 | 0.085 | |
| cellular lipid metabolic process | GO:0044255 | 323 | 0.084 | |
| lymphocyte differentiation | GO:0030098 | 242 | 0.083 | |
| response to organic cyclic compound | GO:0014070 | 198 | 0.083 | |
| protein modification by small protein conjugation or removal | GO:0070647 | 207 | 0.079 | |
| cd8 positive alpha beta t cell proliferation | GO:0035740 | 1 | 0.078 | |
| gland development | GO:0048732 | 330 | 0.076 | |
| regulation of interferon beta biosynthetic process | GO:0045357 | 4 | 0.075 | |
| organic acid transport | GO:0015849 | 101 | 0.075 | |
| purine ribonucleoside triphosphate catabolic process | GO:0009207 | 199 | 0.074 | Human |
| cation transport | GO:0006812 | 399 | 0.073 | |
| regulation of response to biotic stimulus | GO:0002831 | 38 | 0.071 | |
| viral gene expression | GO:0019080 | 3 | 0.071 | |
| negative regulation of toll like receptor signaling pathway | GO:0034122 | 14 | 0.071 | |
| regulation of nlrp3 inflammasome complex assembly | GO:1900225 | 4 | 0.068 | |
| cellular response to interferon alpha | GO:0035457 | 4 | 0.067 | |
| cellular response to biotic stimulus | GO:0071216 | 92 | 0.066 | |
| negative regulation of protein metabolic process | GO:0051248 | 282 | 0.066 | |
| positive regulation of apoptotic process | GO:0043065 | 217 | 0.064 | |
| response to molecule of bacterial origin | GO:0002237 | 143 | 0.064 | |
| divalent inorganic cation transport | GO:0072511 | 178 | 0.063 | |
| response to acid chemical | GO:0001101 | 111 | 0.063 | |
| regulation of type i interferon mediated signaling pathway | GO:0060338 | 7 | 0.062 | |
| regulation of type i interferon production | GO:0032479 | 22 | 0.060 | |
| regulation of cell activation | GO:0050865 | 289 | 0.060 | |
| apoptotic signaling pathway | GO:0097190 | 306 | 0.060 | |
| myeloid dendritic cell differentiation | GO:0043011 | 16 | 0.059 | |
| production of molecular mediator of immune response | GO:0002440 | 103 | 0.058 | |
| macromolecule catabolic process | GO:0009057 | 281 | 0.058 | |
| alpha beta t cell activation | GO:0046631 | 91 | 0.058 | |
| regulation of myd88 dependent toll like receptor signaling pathway | GO:0034124 | 2 | 0.057 | |
| b cell activation | GO:0042113 | 161 | 0.057 | |
| positive regulation of immune effector process | GO:0002699 | 107 | 0.056 | |
| negative regulation of cellular component organization | GO:0051129 | 194 | 0.056 | |
| i kappab kinase nf kappab signaling | GO:0007249 | 85 | 0.056 | |
| b cell activation involved in immune response | GO:0002312 | 50 | 0.056 | |
| regulation of defense response to virus | GO:0050688 | 18 | 0.056 | |
| carbohydrate metabolic process | GO:0005975 | 230 | 0.055 | |
| positive regulation of cell activation | GO:0050867 | 158 | 0.054 | |
| negative regulation of defense response | GO:0031348 | 77 | 0.054 | |
| negative regulation of cytokine production | GO:0001818 | 84 | 0.053 | |
| cytoplasmic transport | GO:0016482 | 234 | 0.053 | |
| positive regulation of cytokine biosynthetic process | GO:0042108 | 40 | 0.052 | |
| regulation of membrane potential | GO:0042391 | 192 | 0.052 | |
| regulation of cellular component biogenesis | GO:0044087 | 181 | 0.051 | |
| regulation of leukocyte mediated immunity | GO:0002703 | 104 | 0.051 | |
| intracellular protein transport | GO:0006886 | 204 | 0.051 | |
| spleen development | GO:0048536 | 39 | 0.051 | |
| regulation of cd8 positive alpha beta t cell proliferation | GO:2000564 | 1 | 0.050 | |
| lymphocyte mediated immunity | GO:0002449 | 139 | 0.050 | |
| myeloid cell homeostasis | GO:0002262 | 114 | 0.050 | |
| alpha beta t cell differentiation | GO:0046632 | 69 | 0.050 | |
| stem cell differentiation | GO:0048863 | 268 | 0.049 | |
| rig i signaling pathway | GO:0039529 | 4 | 0.048 | |
| cell adhesion | GO:0007155 | 329 | 0.048 | |
| nucleoside phosphate biosynthetic process | GO:1901293 | 79 | 0.047 | |
| regulation of interferon gamma production | GO:0032649 | 57 | 0.047 | |
| epithelial cell proliferation | GO:0050673 | 174 | 0.047 | |
| multicellular organismal homeostasis | GO:0048871 | 164 | 0.047 | |
| organophosphate biosynthetic process | GO:0090407 | 122 | 0.047 | |
| nucleotide biosynthetic process | GO:0009165 | 78 | 0.046 | |
| carbohydrate derivative biosynthetic process | GO:1901137 | 183 | 0.046 | |
| cell killing | GO:0001906 | 67 | 0.046 | |
| negative regulation of interferon beta production | GO:0032688 | 3 | 0.046 | |
| transmembrane transport | GO:0055085 | 412 | 0.045 | |
| necrotic cell death | GO:0070265 | 30 | 0.045 | |
| protein catabolic process | GO:0030163 | 221 | 0.044 | |
| cytoplasmic pattern recognition receptor signaling pathway | GO:0002753 | 10 | 0.044 | |
| negative regulation of immune system process | GO:0002683 | 209 | 0.044 | |
| regulation of cd8 positive alpha beta t cell activation | GO:2001185 | 3 | 0.044 | |
| divalent metal ion transport | GO:0070838 | 172 | 0.043 | |
| positive regulation of protein modification process | GO:0031401 | 299 | 0.043 | |
| defense response to protozoan | GO:0042832 | 25 | 0.041 | |
| cellular response to dna damage stimulus | GO:0006974 | 207 | 0.041 | |
| organelle assembly | GO:0070925 | 177 | 0.041 | |
| regulation of transferase activity | GO:0051338 | 263 | 0.040 | |
| peptidyl tyrosine modification | GO:0018212 | 145 | 0.040 | |
| lipid localization | GO:0010876 | 126 | 0.040 | |
| nucleocytoplasmic transport | GO:0006913 | 139 | 0.040 | |
| myeloid cell differentiation | GO:0030099 | 233 | 0.040 | |
| ribose phosphate metabolic process | GO:0019693 | 291 | 0.039 | Human |
| regulation of extrinsic apoptotic signaling pathway | GO:2001236 | 77 | 0.039 | |
| organonitrogen compound biosynthetic process | GO:1901566 | 192 | 0.039 | |
| leukocyte proliferation | GO:0070661 | 172 | 0.039 | |
| negative regulation of growth | GO:0045926 | 99 | 0.039 | |
| extracellular matrix organization | GO:0030198 | 147 | 0.039 | |
| response to interferon gamma | GO:0034341 | 34 | 0.038 | |
| leukocyte mediated cytotoxicity | GO:0001909 | 62 | 0.038 | |
| myd88 independent toll like receptor signaling pathway | GO:0002756 | 3 | 0.038 | |
| adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains | GO:0002460 | 145 | 0.038 | |
| positive regulation of leukocyte mediated cytotoxicity | GO:0001912 | 31 | 0.038 | |
| myeloid leukocyte differentiation | GO:0002573 | 119 | 0.038 | |
| nucleoside phosphate metabolic process | GO:0006753 | 338 | 0.038 | Human |
| dna metabolic process | GO:0006259 | 303 | 0.037 | |
| nuclear transport | GO:0051169 | 139 | 0.037 | |
| ribonucleoside triphosphate metabolic process | GO:0009199 | 220 | 0.037 | Human |
| regulation of peptidase activity | GO:0052547 | 96 | 0.037 | |
| positive regulation of sequence specific dna binding transcription factor activity | GO:0051091 | 68 | 0.037 | |
| purine nucleotide biosynthetic process | GO:0006164 | 65 | 0.037 | |
| mammary gland epithelium development | GO:0061180 | 65 | 0.037 | |
| reactive oxygen species biosynthetic process | GO:1903409 | 8 | 0.037 | |
| type i interferon signaling pathway | GO:0060337 | 10 | 0.036 | |
| neuronal action potential | GO:0019228 | 54 | 0.036 | |
| positive regulation of natural killer cell mediated immunity | GO:0002717 | 16 | 0.036 | |
| regulation of interleukin 12 production | GO:0032655 | 30 | 0.036 | |
| epithelial cell development | GO:0002064 | 159 | 0.036 | |
| reactive oxygen species metabolic process | GO:0072593 | 84 | 0.036 | |
| glycosyl compound catabolic process | GO:1901658 | 206 | 0.036 | Human |
| homeostasis of number of cells | GO:0048872 | 210 | 0.036 | |
| protein localization to nucleus | GO:0034504 | 121 | 0.036 | |
| biomineral tissue development | GO:0031214 | 64 | 0.036 | |
| cellular response to cytokine stimulus | GO:0071345 | 189 | 0.035 | |
| monocarboxylic acid metabolic process | GO:0032787 | 191 | 0.035 | |
| regulation of leukocyte differentiation | GO:1902105 | 159 | 0.035 | |
| ion transmembrane transport | GO:0034220 | 361 | 0.035 | |
| protein localization to organelle | GO:0033365 | 185 | 0.035 | |
| multicellular organismal signaling | GO:0035637 | 91 | 0.034 | |
| posttranscriptional regulation of gene expression | GO:0010608 | 155 | 0.034 | |
| protein methylation | GO:0006479 | 81 | 0.034 | |
| regulation of kinase activity | GO:0043549 | 249 | 0.034 | |
| transmission of nerve impulse | GO:0019226 | 76 | 0.034 | |
| regulation of lymphocyte differentiation | GO:0045619 | 107 | 0.034 | |
| purine containing compound metabolic process | GO:0072521 | 311 | 0.034 | Human |
| wound healing | GO:0042060 | 157 | 0.034 | |
| cellular ketone metabolic process | GO:0042180 | 84 | 0.034 | |
| positive regulation of lymphocyte activation | GO:0051251 | 140 | 0.034 | |
| regulation of proteolysis | GO:0030162 | 164 | 0.034 | |
| positive regulation of cellular amine metabolic process | GO:0033240 | 5 | 0.033 | |
| positive regulation of cell death | GO:0010942 | 224 | 0.033 | |
| regulation of reactive oxygen species metabolic process | GO:2000377 | 40 | 0.033 | |
| leukocyte activation involved in immune response | GO:0002366 | 126 | 0.033 | |
| regulation of protein catabolic process | GO:0042176 | 108 | 0.033 | |
| cellular macromolecule catabolic process | GO:0044265 | 206 | 0.033 | |
| atp metabolic process | GO:0046034 | 75 | 0.033 | Human |
| negative regulation of cell development | GO:0010721 | 169 | 0.033 | |
| negative regulation of nlrp3 inflammasome complex assembly | GO:1900226 | 2 | 0.033 | |
| purine nucleotide metabolic process | GO:0006163 | 302 | 0.032 | Human |
| morphogenesis of a branching epithelium | GO:0061138 | 193 | 0.032 | |
| toll like receptor 7 signaling pathway | GO:0034154 | 4 | 0.032 | |
| cation transmembrane transport | GO:0098655 | 266 | 0.032 | |
| immunoglobulin mediated immune response | GO:0016064 | 69 | 0.032 | |
| purine ribonucleotide metabolic process | GO:0009150 | 290 | 0.032 | Human |
| regulation of hormone levels | GO:0010817 | 211 | 0.032 | |
| t cell differentiation | GO:0030217 | 174 | 0.031 | |
| regulation of protein complex assembly | GO:0043254 | 83 | 0.031 | |
| negative regulation of viral transcription | GO:0032897 | 3 | 0.031 | |
| aromatic compound catabolic process | GO:0019439 | 286 | 0.031 | Human |
| positive regulation of nf kappab transcription factor activity | GO:0051092 | 30 | 0.031 | |
| regulation of secretion | GO:0051046 | 274 | 0.031 | |
| interaction with host | GO:0051701 | 22 | 0.031 | |
| regulation of cytokine biosynthetic process | GO:0042035 | 59 | 0.031 | |
| cytokine mediated signaling pathway | GO:0019221 | 115 | 0.031 | |
| positive regulation of interferon beta production | GO:0032728 | 8 | 0.031 | |
| glycosyl compound metabolic process | GO:1901657 | 246 | 0.031 | Human |
| positive regulation of proteolysis | GO:0045862 | 85 | 0.030 | |
| myeloid leukocyte activation | GO:0002274 | 83 | 0.030 | |
| cytoplasmic pattern recognition receptor signaling pathway in response to virus | GO:0039528 | 4 | 0.030 | |
| regulation of adaptive immune response | GO:0002819 | 90 | 0.030 | |
| positive regulation of mapk cascade | GO:0043410 | 170 | 0.030 | |
| regulation of interleukin 6 production | GO:0032675 | 55 | 0.030 | |
| reactive nitrogen species metabolic process | GO:2001057 | 0 | 0.030 | |
| interferon gamma production | GO:0032609 | 67 | 0.030 | |
| protein import | GO:0017038 | 101 | 0.030 | |
| chromatin organization | GO:0006325 | 206 | 0.030 | |
| forebrain development | GO:0030900 | 302 | 0.029 | |
| peptidyl tyrosine phosphorylation | GO:0018108 | 143 | 0.029 | |
| negative regulation of phosphorylation | GO:0042326 | 166 | 0.029 | |
| peptidyl amino acid modification | GO:0018193 | 336 | 0.029 | |
| response to dsrna | GO:0043331 | 30 | 0.029 | |
| calcium ion transport | GO:0006816 | 159 | 0.029 | |
| regulation of cell motility | GO:2000145 | 236 | 0.029 | |
| nucleobase containing small molecule metabolic process | GO:0055086 | 352 | 0.029 | Human |
| regulation of cellular ketone metabolic process | GO:0010565 | 66 | 0.029 | |
| anatomical structure homeostasis | GO:0060249 | 145 | 0.029 | |
| cell type specific apoptotic process | GO:0097285 | 268 | 0.029 | |
| cellular amino acid metabolic process | GO:0006520 | 103 | 0.029 | |
| gene silencing by mirna | GO:0035195 | 10 | 0.029 | |
| positive regulation of interferon gamma production | GO:0032729 | 39 | 0.028 | |
| t cell proliferation | GO:0042098 | 120 | 0.028 | |
| cation homeostasis | GO:0055080 | 212 | 0.028 | |
| single organism nuclear import | GO:1902593 | 95 | 0.028 | |
| tissue remodeling | GO:0048771 | 102 | 0.028 | |
| anion transport | GO:0006820 | 177 | 0.028 | |
| purine ribonucleoside metabolic process | GO:0046128 | 241 | 0.028 | Human |
| regulation of cellular amino acid metabolic process | GO:0006521 | 5 | 0.028 | |
| negative regulation of molecular function | GO:0044092 | 258 | 0.028 | |
| negative regulation of viral entry into host cell | GO:0046597 | 10 | 0.027 | |
| protein maturation | GO:0051604 | 176 | 0.027 | |
| cell activation involved in immune response | GO:0002263 | 126 | 0.027 | |
| regulation of protein transport | GO:0051223 | 163 | 0.027 | |
| positive regulation of protein kinase activity | GO:0045860 | 144 | 0.027 | |
| cytokine metabolic process | GO:0042107 | 71 | 0.027 | |
| regulation of protein localization | GO:0032880 | 231 | 0.027 | |
| stem cell development | GO:0048864 | 219 | 0.027 | |
| myd88 dependent toll like receptor signaling pathway | GO:0002755 | 7 | 0.027 | |
| cellular amine metabolic process | GO:0044106 | 44 | 0.026 | |
| regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains | GO:0002822 | 87 | 0.026 | |
| cellular nitrogen compound catabolic process | GO:0044270 | 280 | 0.026 | Human |
| organic cyclic compound catabolic process | GO:1901361 | 295 | 0.026 | Human |
| protein targeting | GO:0006605 | 143 | 0.026 | |
| protein processing | GO:0016485 | 163 | 0.026 | |
| cd4 positive alpha beta t cell lineage commitment | GO:0043373 | 6 | 0.026 | |
| protein oligomerization | GO:0051259 | 67 | 0.026 | Mouse |
| positive regulation of programmed cell death | GO:0043068 | 218 | 0.026 | |
| cellular metal ion homeostasis | GO:0006875 | 151 | 0.026 | |
| regulation of cysteine type endopeptidase activity | GO:2000116 | 65 | 0.026 | |
| positive regulation of kinase activity | GO:0033674 | 155 | 0.026 | |
| maintenance of location | GO:0051235 | 89 | 0.026 | |
| response to radiation | GO:0009314 | 165 | 0.025 | |
| regulation of secretion by cell | GO:1903530 | 249 | 0.025 | |
| epithelial tube morphogenesis | GO:0060562 | 303 | 0.025 | |
| citrate metabolic process | GO:0006101 | 3 | 0.025 | |
| regulation of tumor necrosis factor production | GO:0032680 | 49 | 0.025 | |
| regulation of b cell activation | GO:0050864 | 81 | 0.025 | |
| regulation of leukocyte proliferation | GO:0070663 | 121 | 0.025 | |
| response to organonitrogen compound | GO:0010243 | 246 | 0.025 | |
| microtubule cytoskeleton organization | GO:0000226 | 157 | 0.025 | |
| female sex differentiation | GO:0046660 | 84 | 0.025 | |
| type i interferon biosynthetic process | GO:0045351 | 9 | 0.025 | |
| negative regulation of nervous system development | GO:0051961 | 156 | 0.025 | |
| b cell mediated immunity | GO:0019724 | 71 | 0.025 | |
| interleukin 6 production | GO:0032635 | 58 | 0.025 | |
| regulation of cysteine type endopeptidase activity involved in apoptotic process | GO:0043281 | 62 | 0.025 | |
| regulation of homeostatic process | GO:0032844 | 182 | 0.025 | |
| response to hypoxia | GO:0001666 | 58 | 0.024 | |
| ossification | GO:0001503 | 216 | 0.024 | |
| skin development | GO:0043588 | 220 | 0.024 | |
| nuclear import | GO:0051170 | 95 | 0.024 | |
| regulation of lymphocyte mediated immunity | GO:0002706 | 84 | 0.024 | |
| endocytosis | GO:0006897 | 168 | 0.024 | |
| nucleotide metabolic process | GO:0009117 | 332 | 0.024 | Human |
| mast cell proliferation | GO:0070662 | 4 | 0.024 | |
| negative regulation of regulatory t cell differentiation | GO:0045590 | 2 | 0.024 | |
| alpha beta t cell activation involved in immune response | GO:0002287 | 31 | 0.024 | |
| regulation of cell adhesion | GO:0030155 | 154 | 0.024 | |
| negative regulation of viral release from host cell | GO:1902187 | 6 | 0.024 | |
| positive regulation of transferase activity | GO:0051347 | 167 | 0.024 | |
| regulation of organ morphogenesis | GO:2000027 | 144 | 0.023 | |
| response to peptide | GO:1901652 | 136 | 0.023 | |
| positive regulation of viral genome replication | GO:0045070 | 2 | 0.023 | |
| regulation of cellular amine metabolic process | GO:0033238 | 20 | 0.023 | |
| positive regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains | GO:0002824 | 61 | 0.023 | |
| cd4 positive alpha beta t cell activation | GO:0035710 | 45 | 0.023 | |
| regulation of leukocyte mediated cytotoxicity | GO:0001910 | 38 | 0.023 | |
| negative regulation of immune effector process | GO:0002698 | 55 | 0.023 | |
| natural killer cell mediated cytotoxicity | GO:0042267 | 29 | 0.023 | |
| nucleoside catabolic process | GO:0009164 | 206 | 0.023 | Human |
| regulation of t cell differentiation | GO:0045580 | 83 | 0.023 | |
| viral transcription | GO:0019083 | 3 | 0.022 | |
| branching morphogenesis of an epithelial tube | GO:0048754 | 159 | 0.022 | |
| natural killer cell mediated immunity | GO:0002228 | 29 | 0.022 | |
| cellular protein catabolic process | GO:0044257 | 155 | 0.022 | |
| cell substrate adhesion | GO:0031589 | 130 | 0.022 | |
| regulation of cell migration | GO:0030334 | 219 | 0.022 | |
| glial cell differentiation | GO:0010001 | 131 | 0.022 | |
| multicellular organism growth | GO:0035264 | 161 | 0.022 | |
| positive regulation of protein phosphorylation | GO:0001934 | 242 | 0.022 | |
| cellularization | GO:0007349 | 1 | 0.022 | |
| cd4 positive alpha beta t cell differentiation | GO:0043367 | 41 | 0.022 | |
| positive regulation of rig i signaling pathway | GO:1900246 | 1 | 0.021 | |
| spermatogenesis | GO:0007283 | 284 | 0.021 | |
| lung development | GO:0030324 | 164 | 0.021 | |
| rna interference | GO:0016246 | 2 | 0.021 | |
| germ cell development | GO:0007281 | 185 | 0.021 | |
| positive regulation of cysteine type endopeptidase activity involved in apoptotic process | GO:0043280 | 36 | 0.021 | |
| nitrogen compound transport | GO:0071705 | 271 | 0.021 | |
| positive regulation of leukocyte differentiation | GO:1902107 | 86 | 0.021 | |
| ribonucleotide metabolic process | GO:0009259 | 291 | 0.021 | Human |
| regulation of alpha beta t cell activation | GO:0046634 | 53 | 0.021 | |
| protein import into nucleus | GO:0006606 | 95 | 0.021 | |
| regulation of organelle organization | GO:0033043 | 289 | 0.021 | |
| positive regulation of cell killing | GO:0031343 | 33 | 0.021 | |
| b cell differentiation | GO:0030183 | 78 | 0.021 | |
| pyrimidine containing compound catabolic process | GO:0072529 | 3 | 0.021 | |
| purine nucleoside metabolic process | GO:0042278 | 241 | 0.021 | Human |
| regulation of mapk cascade | GO:0043408 | 248 | 0.021 | |
| t cell mediated cytotoxicity | GO:0001913 | 26 | 0.021 | |
| protein acylation | GO:0043543 | 64 | 0.021 | |
| positive regulation of t cell activation | GO:0050870 | 101 | 0.020 | |
| leukocyte apoptotic process | GO:0071887 | 71 | 0.020 | |
| negative regulation of innate immune response | GO:0045824 | 17 | 0.020 | |
| entry into cell of other organism involved in symbiotic interaction | GO:0051806 | 15 | 0.020 | |
| respiratory tube development | GO:0030323 | 167 | 0.020 | |
| regulation of schwann cell proliferation | GO:0010624 | 2 | 0.020 | |
| organonitrogen compound catabolic process | GO:1901565 | 264 | 0.020 | Human |
| spermatid differentiation | GO:0048515 | 115 | 0.020 | |
| morphogenesis of a branching structure | GO:0001763 | 203 | 0.020 | |
| lymphocyte proliferation | GO:0046651 | 164 | 0.020 | |
| positive regulation of leukocyte mediated immunity | GO:0002705 | 70 | 0.020 | |
| modification dependent protein catabolic process | GO:0019941 | 133 | 0.020 | |
| compound eye development | GO:0048749 | 1 | 0.020 | |
| somatic recombination of immunoglobulin genes involved in immune response | GO:0002204 | 36 | 0.020 | |
| positive regulation of cellular component biogenesis | GO:0044089 | 94 | 0.020 | |
| maintenance of protein location in nucleus | GO:0051457 | 2 | 0.020 | |
| hematopoietic progenitor cell differentiation | GO:0002244 | 143 | 0.020 | |
| cellular homeostasis | GO:0019725 | 240 | 0.020 | |
| peripheral nervous system development | GO:0007422 | 53 | 0.019 | |
| gonad development | GO:0008406 | 141 | 0.019 | |
| mapk cascade | GO:0000165 | 281 | 0.019 | |
| calcium ion homeostasis | GO:0055074 | 127 | 0.019 | |
| fatty acid metabolic process | GO:0006631 | 121 | 0.019 | |
| regulation of binding | GO:0051098 | 111 | 0.019 | |
| molting cycle | GO:0042303 | 90 | 0.019 | |
| protein ubiquitination | GO:0016567 | 171 | 0.019 | |
| limb development | GO:0060173 | 166 | 0.019 | |
| positive regulation of adaptive immune response | GO:0002821 | 61 | 0.019 | |
| programmed necrotic cell death | GO:0097300 | 28 | 0.019 | |
| ribonucleoside catabolic process | GO:0042454 | 206 | 0.019 | Human |
| small gtpase mediated signal transduction | GO:0007264 | 97 | 0.019 | |
| inorganic cation transmembrane transport | GO:0098662 | 207 | 0.019 | |
| mammary gland morphogenesis | GO:0060443 | 54 | 0.019 | |
| regulation of reactive oxygen species biosynthetic process | GO:1903426 | 2 | 0.019 | |
| positive regulation of interleukin 12 production | GO:0032735 | 21 | 0.019 | |
| response to granulocyte macrophage colony stimulating factor | GO:0097012 | 3 | 0.019 | |
| inorganic ion transmembrane transport | GO:0098660 | 234 | 0.019 | |
| regulation of cell cycle | GO:0051726 | 281 | 0.019 | |
| regulation of defense response to bacterium | GO:1900424 | 3 | 0.019 | |
| synaptic transmission | GO:0007268 | 329 | 0.019 | |
| regulation of cytoskeleton organization | GO:0051493 | 122 | 0.019 | |
| sensory perception | GO:0007600 | 245 | 0.019 | |
| t helper cell lineage commitment | GO:0002295 | 6 | 0.019 | |
| regulation of mast cell proliferation | GO:0070666 | 4 | 0.019 | |
| peptidyl lysine methylation | GO:0018022 | 29 | 0.019 | |
| negative regulation of interferon beta biosynthetic process | GO:0045358 | 1 | 0.018 | |
| angiogenesis | GO:0001525 | 201 | 0.018 | |
| regulation of response to wounding | GO:1903034 | 189 | 0.018 | |
| t helper 17 cell differentiation | GO:0072539 | 7 | 0.018 | |
| extrinsic apoptotic signaling pathway via death domain receptors | GO:0008625 | 34 | 0.018 | |
| somatic diversification of immunoglobulins involved in immune response | GO:0002208 | 36 | 0.018 | |
| regulation of metal ion transport | GO:0010959 | 106 | 0.018 | |
| proteolysis involved in cellular protein catabolic process | GO:0051603 | 147 | 0.018 | |
| action potential | GO:0001508 | 78 | 0.018 | |
| stem cell maintenance | GO:0019827 | 130 | 0.018 | |
| regulation of cell killing | GO:0031341 | 40 | 0.018 | |
| t cell activation | GO:0042110 | 289 | 0.018 | |
| regulation of mitotic cell cycle | GO:0007346 | 126 | 0.018 | |
| regulation of natural killer cell mediated immunity | GO:0002715 | 19 | 0.018 | |
| spermatid development | GO:0007286 | 108 | 0.018 | |
| organic anion transport | GO:0015711 | 137 | 0.018 | |
| multi multicellular organism process | GO:0044706 | 109 | 0.018 | |
| cellular chemical homeostasis | GO:0055082 | 215 | 0.018 | |
| purine containing compound catabolic process | GO:0072523 | 213 | 0.018 | Human |
| regulation of viral transcription | GO:0046782 | 3 | 0.018 | |
| macromolecule methylation | GO:0043414 | 120 | 0.018 | |
| negative regulation of cellular protein metabolic process | GO:0032269 | 247 | 0.017 | |
| chromatin modification | GO:0016568 | 187 | 0.017 | |
| positive regulation of peptidase activity | GO:0010952 | 49 | 0.017 | |
| t cell activation involved in immune response | GO:0002286 | 43 | 0.017 | |
| regulation of system process | GO:0044057 | 200 | 0.017 | |
| purine nucleoside triphosphate catabolic process | GO:0009146 | 203 | 0.017 | Human |
| carboxylic acid transport | GO:0046942 | 100 | 0.017 | |
| mitotic cell cycle process | GO:1903047 | 159 | 0.017 | |
| olfactory learning | GO:0008355 | 2 | 0.017 | |
| response to oxygen levels | GO:0070482 | 62 | 0.017 | |
| regulation of actin nucleation | GO:0051125 | 4 | 0.017 | |
| proteasomal protein catabolic process | GO:0010498 | 98 | 0.017 | |
| sensory perception of sound | GO:0007605 | 97 | 0.017 | |
| mesenchyme development | GO:0060485 | 152 | 0.017 | |
| purine nucleoside triphosphate metabolic process | GO:0009144 | 226 | 0.017 | Human |
| protein alkylation | GO:0008213 | 81 | 0.017 | |
| regulation of lymphocyte proliferation | GO:0050670 | 117 | 0.017 | |
| cell fate commitment | GO:0045165 | 210 | 0.017 | |
| somatic recombination of immunoglobulin gene segments | GO:0016447 | 42 | 0.017 | |
| positive regulation of response to cytokine stimulus | GO:0060760 | 11 | 0.017 | |
| somatic diversification of immune receptors | GO:0002200 | 53 | 0.017 | |
| limb morphogenesis | GO:0035108 | 149 | 0.017 | |
| nucleoside metabolic process | GO:0009116 | 246 | 0.017 | Human |
| natural killer cell proliferation | GO:0001787 | 3 | 0.017 | |
| negative regulation of defense response to virus by host | GO:0050689 | 1 | 0.017 | |
| regulation of interleukin 1 alpha production | GO:0032650 | 4 | 0.017 | |
| histone modification | GO:0016570 | 159 | 0.017 | |
| organophosphate catabolic process | GO:0046434 | 232 | 0.017 | Human |
| regulation of t cell mediated cytotoxicity | GO:0001914 | 18 | 0.017 | |
| activation of cysteine type endopeptidase activity involved in apoptotic process | GO:0006919 | 27 | 0.017 | |
| modification dependent macromolecule catabolic process | GO:0043632 | 133 | 0.016 | |
| phospholipid transfer to membrane | GO:0006649 | 2 | 0.016 | |
| positive regulation of intracellular transport | GO:0032388 | 70 | 0.016 | |
| digestive system development | GO:0055123 | 200 | 0.016 | |
| protein autophosphorylation | GO:0046777 | 61 | 0.016 | |
| regulation of establishment of protein localization | GO:0070201 | 181 | 0.016 | |
| purine nucleoside monophosphate metabolic process | GO:0009126 | 81 | 0.016 | Human |
| blood vessel morphogenesis | GO:0048514 | 285 | 0.016 | |
| muscle cell differentiation | GO:0042692 | 261 | 0.016 | |
| male gamete generation | GO:0048232 | 285 | 0.016 | |
| negative regulation of phosphorus metabolic process | GO:0010563 | 184 | 0.016 | |
| intracellular receptor signaling pathway | GO:0030522 | 74 | 0.016 | |
| response to decreased oxygen levels | GO:0036293 | 59 | 0.016 | |
| regulation of lymphocyte activation | GO:0051249 | 240 | 0.016 | |
| alpha beta t cell differentiation involved in immune response | GO:0002293 | 30 | 0.016 | |
| negative regulation of t cell activation | GO:0050868 | 65 | 0.016 | |
| somatic diversification of immunoglobulins | GO:0016445 | 43 | 0.016 | |
| amino acid transport | GO:0006865 | 61 | 0.016 | |
| ear development | GO:0043583 | 200 | 0.016 | |
| glycosylation | GO:0070085 | 62 | 0.016 | |
| cellular response to interferon gamma | GO:0071346 | 25 | 0.016 | |
| negative regulation of extrinsic apoptotic signaling pathway | GO:2001237 | 45 | 0.016 | |
| positive regulation of apoptotic signaling pathway | GO:2001235 | 95 | 0.016 | |
| negative regulation of phosphate metabolic process | GO:0045936 | 184 | 0.016 | |
| somatic cell dna recombination | GO:0016444 | 51 | 0.016 | |
| immune response activating cell surface receptor signaling pathway | GO:0002429 | 72 | 0.015 | |
| regulation of natural killer cell mediated cytotoxicity | GO:0042269 | 19 | 0.015 | |
| positive regulation of lymphocyte differentiation | GO:0045621 | 61 | 0.015 | |
| regulation of hydrolase activity | GO:0051336 | 246 | 0.015 | |
| nucleoside triphosphate catabolic process | GO:0009143 | 205 | 0.015 | Human |
| positive regulation of cellular amino acid metabolic process | GO:0045764 | 3 | 0.015 | |
| dna dealkylation | GO:0035510 | 11 | 0.015 | |
| schwann cell proliferation | GO:0014010 | 2 | 0.015 | |
| positive regulation of growth | GO:0045927 | 104 | 0.015 | |
| regulation of protein processing | GO:0070613 | 96 | 0.015 | |
| t cell lineage commitment | GO:0002360 | 13 | 0.015 | |
| regulation of body fluid levels | GO:0050878 | 162 | 0.015 | |
| cellular calcium ion homeostasis | GO:0006874 | 119 | 0.015 | |
| amine metabolic process | GO:0009308 | 45 | 0.015 | |
| sodium ion transport | GO:0006814 | 73 | 0.015 | |
| t helper cell differentiation | GO:0042093 | 28 | 0.015 | |
| immunoglobulin production | GO:0002377 | 73 | 0.015 | |
| ribonucleoside metabolic process | GO:0009119 | 245 | 0.015 | Human |
| response to interferon alpha | GO:0035455 | 7 | 0.015 | |
| divalent inorganic cation homeostasis | GO:0072507 | 138 | 0.015 | |
| regulation of calcium ion transport | GO:0051924 | 69 | 0.015 | |
| regulation of purine nucleotide metabolic process | GO:1900542 | 169 | 0.015 | |
| proteasome mediated ubiquitin dependent protein catabolic process | GO:0043161 | 88 | 0.015 | |
| glucose transport | GO:0015758 | 56 | 0.015 | |
| regulation of viral release from host cell | GO:1902186 | 6 | 0.015 | |
| ribonucleoside triphosphate catabolic process | GO:0009203 | 199 | 0.015 | Human |
| response to ionizing radiation | GO:0010212 | 42 | 0.015 | |
| lymphocyte apoptotic process | GO:0070227 | 54 | 0.015 | |
| gene silencing | GO:0016458 | 38 | 0.015 | |
| entry into host cell | GO:0030260 | 15 | 0.014 | |
| intrinsic apoptotic signaling pathway | GO:0097193 | 132 | 0.014 | |
| cellular amide metabolic process | GO:0043603 | 58 | 0.014 | |
| striated muscle tissue development | GO:0014706 | 293 | 0.014 | |
| lipoprotein metabolic process | GO:0042157 | 43 | 0.014 | |
| regulation of ossification | GO:0030278 | 112 | 0.014 | |
| purine ribonucleotide catabolic process | GO:0009154 | 208 | 0.014 | Human |
| cellular response to prostaglandin d stimulus | GO:0071799 | 1 | 0.014 | |
